Cargando…
Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats.
The role of cholecystokinin in dietary fat-promoted pancreatic carcinogenesis was investigated in azaserine-treated rats, using lorglumide, a highly specific cholecystokinin-receptor antagonist. The animals were killed 8 months after the start of treatment. Cholecystokinin, but not dietary unsaturat...
Autores principales: | Appel, M. J., Meijers, M., Van Garderen-Hoetmer, A., Lamers, C. B., Rovati, L. C., Sprij-Mooij, D., Jansen, J. B., Woutersen, R. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977907/ https://www.ncbi.nlm.nih.gov/pubmed/1637675 |
Ejemplares similares
-
Dietary fish oil (MaxEPA) enhances pancreatic carcinogenesis in azaserine-treated rats.
por: Appel, M. J., et al.
Publicado: (1996) -
Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine.
por: Visser, C. J., et al.
Publicado: (1996) -
Pancreatic carcinogenesis-enhancement by cholecystokinin in the hamster-nitrosamine model.
por: Howatson, A. G., et al.
Publicado: (1985) -
Lesions induced in rodent pancreas by azaserine and other pancreatic carcinogens.
por: Longnecker, D S
Publicado: (1984) -
Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
por: Watanapa, P., et al.
Publicado: (1993)